Best Choice will not ship Monday, Oct 26. Best Choice orders placed over the weekend or on Monday ship Tuesday, Oct 27.

FDA daily

FDA daily for Thursday, October 15, 2026

In this issue: 28 shortage updates, 17 approvals, 19 device decisions and 6 label changes. 2 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug shortages

FDA date:

FDA updated 28 shortage entries on Wed, Oct 14: 2 new, 2 to be discontinued, 24 status updates.

Browse drug shortages in FDA data →

Drug and biologic approvals

FDA date:

On Thu, Oct 8 FDA approved 3 new applications (2 brand or biologic, 1 generic) and 14 supplements to existing ones.

  • PITOLISANT HYDROCHLORIDE

    ANNORA PHARMA · PITOLISANT HYDROCHLORIDE

    ANDA218832Generic (ANDA)Prescription
  • WELTRUZA

    TEVA NEUROSCIENCE INC · OLANZAPINE

    NDA219007Drug (NDA)Prescription
  • BREZTRI AEROSPHERE

    ASTRAZENECA AB · BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE

    NDA220290Drug (NDA)Prescription
Browse drug and biologic approvals in FDA data →

Device clearances and approvals

FDA date:

FDA decided 10 510(k)s and 9 PMA decisions on Thu, Oct 1, including 1 original PMA.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

6 drug labels took effect on Thu, Oct 1.

Browse label updates in FDA data →

FDA did not answer for Food and supplement recalls, Drug recalls, Device recalls while this issue was written; those sections will fill in on a later visit.

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.